Prognostic role of COVID-19 pneumonia signs and other CT-biomarkers for survival in patients with malignant neoplasms: the ARILUS project
Dyachenko, A. A.; Bogdanov, M. A.; Bogdanov, D. V.; Grjibovski, A. M.; Nazarova, E. A.; Meldo, A. A.; Chernina, V. Y.; Gombolevskiy, V. A.; Valkov, M. Y.
Show abstract
BackgroundClinically manifested pneumonia associated with COVID-19 infection in cancer patients has been associated with worse prognosis. The prognostic significance of subclinical manifestations of pulmonary infiltration is poorly understood. AimsTo estimate the survival of cancer patients with signs of asymptomatic pneumonia detected by a multitarget artificial intelligence (AI) algorithm on chest computed tomography (CT) during the COVID-19 pandemic, and to evaluate factors associated with the risk of death in this population. Materials and methodsThis population-based cohort study, conducted within the ARILUS project, included 1,147 examinations of cancer patients performed between August 2020 and May 2021. Signs of pneumonia on CT were detected by the AI algorithm in 556 (48.4%) patients with malignant neoplasms (MN) who had no clinical manifestations of infection at the time of the examination. Overall survival (OS) was assessed using the life table and Kaplan-Meier methods. Multivariate Cox proportional hazards regression analysis was used to identify independent predictors of death and to assess the influence of potential confounding factors. ResultsDuring the follow-up period, 680 deaths were recorded among cancer patients, of which 575 deaths were due to MN progression. Three-year OS differed significantly between the groups: in patients without signs of pulmonary infiltration on CT, it was 60.7% (95% CI 56.6%- 64.7%), whereas in patients with AI-detected signs of pneumonia, it was 45.6% (95% CI 41.3%- 49.8%) (p<0.001). In the multivariable regression analysis, independent factors associated with an unfavorable prognosis (death) were: presence of pulmonary infiltration (adjusted hazard ratio (HR) 1.31; 95% CI 1.09-1.58), male sex (HR 1.25; 95% CI 1.00-1.57), and MN stage (HR 1.78 for stage II, HR 2.93 for stage III, and HR 4.74 for stage IV compared to stage I). Signs of pulmonary emphysema (HR 1.84), aortic aneurysm (HR 1.75), and coronary artery calcification (HR 1.22-1.34), which were significantly associated with the risk of death in the univariable analysis, lost their prognostic significance in the multivariable model after adjustment for other variables. ConclusionsAsymptomatic COVID-19 pneumonia detected by AI on CT is an independent predictor of reduced overall survival in MN patients. Automated AI screening for such changes may be recommended in routine practice.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Accurate diagnosis of high-risk pulmonary nodules using a non-invasive epigenetic biomarker test 93%
- Use of high-plex data reveals novel insights into the tumour microenvironment of clear cell renal cell carcinoma 93%
- KRAS mutations impact clinical outcome in metastatic non-small cell lung cancer 92%
Similar papers in this journal
- Chest X-Ray Has Poor Diagnostic Accuracy and Prognostic Significance in COVID-19: A Propensity Matched Database Study 93%
- Patterns of peritoneal dissemination and response to systemic chemotherapy in common and rare peritoneal tumors treated by cytoreductive surgery: Study protocol of a prospective, multi-center, observational study 93%
- Point-of-care lung ultrasonography for early identification of mild COVID-19: a prospective cohort of outpatients in a Swiss screening center 93%
Similar papers in this journal
- Navigated ultrasound bronchoscopy with integrated positron emission tomography - A human feasibility study 93%
- Prevalence of Lung Cancer in Colombia and a New Diagnostic Algorithm Using Health Administrative Databases: A Real-World Evidence Study 93%
- Accuracy of deep learning based computed tomography diagnostic system of COVID-19: a consecutive sampling external validation cohort study 93%
Similar papers in this journal
- Volumetric lung cancer screening reduces unnecessary low-dose computed tomography scans: results from a single-centre prospective trial on 4,119 subjects 94%
- Passive Microwave Radiometry (MWR) for diagnostics of COVID-19 lung complications in Kyrgyzstan 93%
- The NILS study protocol - a retrospective validation study of a preoperative decision-making tool for non-invasive lymph node staging in women with primary breast cancer [ISRCTN14341750] 92%
Similar papers in this journal
- Underlying reasons for post-mortem diagnosed lung cancer cases – A robust retrospective comparative study from Hungary (HULC study) 93%
- Factors affecting COVID-19 outcomes in cancer patients - A first report from Guys Cancer Centre in London 93%
- Circulating tumor fraction analyses with ultra-low pass whole genome sequencing predict response to chemoradiation and recurrence in stage IV small cell carcinoma of the cervix: a longitudinal case study 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.